NSC |
Compound |
Enrichment |
Correlation |
NSC 622926 |
Null |
0.000432107380838963 |
-0.33057306 |
NSC 647638 |
1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) |
0.000432107380838963 |
0.46651054 |
NSC 756468 |
SB-725317 |
0.000447018739023986 |
0.30091239 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.000464023138983832 |
0.37103051 |
NSC 136468 |
Null |
0.000464023138983839 |
0.52246326 |
NSC 149286 |
1,4-Pentadien-3-one, 1,5-di-3-pyridyl- |
0.000464023138983839 |
0.52350153 |
NSC 335766 |
Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- |
0.000464023138983839 |
0.54080282 |
NSC 628114 |
9-N(N'-chloroethyl-N'-ethyl-1,2-diaminoethyl) 2-methoxyacridine dihydrochloride |
0.000464023138983839 |
0.57061221 |
NSC 641177 |
Null |
0.000464023138983839 |
0.47582155 |
NSC 687330 |
Adenosine, 2'-amino-2'-deoxy-3',5'- O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]- (9CI) |
0.000464023138983839 |
0.3095798 |